𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pressure dependence of bicimer formation in 4-dimethylamino-4'-cyanostilbene and model compounds

✍ Scribed by W. Rettig; E. Gilabert; C. Rulliére

Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
523 KB
Volume
229
Category
Article
ISSN
0009-2614

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Spectroscopy and dynamics of jet-cooled
Spectroscopy and dynamics of jet-cooled 4-dimethylamino-4′-cyanostilbene in the S1 state
✍ Rainer Daum; Tony Hansson; Ralf Nörenberg; Dirk Schwarzer; Jörg Schroeder 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 584 KB

The S I state of jet-cooled 4-(N,N-dimethylamino)-4'-cyanostilbene (DCS) was studied by picosecond fluorescence spectroscopy. The line structure of the S O -\* Sl-excitation spectrum is a superposition of transitions characteristic of isolated trans-sti~bene and the dimethylamino group. Rotational c

The synthesis of 3-[(dimethylamino)(2-ph
The synthesis of 3-[(dimethylamino)(2-phenyl-5-oxo-2-oxazolinyl-idene-4)methyl]imidazo[1,2-x]azines and related compounds, intermediates in the formation of azaaplysinopsin derivatives
✍ Urška Bratušek; Aleš Hvala; Branko Stanovnik 📂 Article 📅 1998 🏛 Journal of Heterocyclic Chemistry 🌐 English ⚖ 510 KB

## Abstract 4‐(2‐Bromo‐1‐dimethylaminoethylidene)‐2‐phenyl‐5(4__H__)‐oxazolone (5) reacts with __N,N__‐dimethyl‐__N'‐__heteroarylformamidines 7 to form imidazoazine derivatives 9 with the oxazolone ring connected through a conjugated double bond to the fused imidazole system at position 3. Compound

Schedule dependence of combretastatin A4
Schedule dependence of combretastatin A4 phosphate in transplanted and spontaneous tumour models
✍ Sally A. Hill; David J. Chaplin; Gemma Lewis; Gillian M. Tozer 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 645 KB

## Abstract Tubulin depolymerizing drugs that selectively disrupt tumour‐associated vasculature have recently been identified. The lead drug in this class, combretastatin A4 phosphate (CA4P), has just completed Phase I clinical trial. Previous studies have focussed on the effects of single drug dos